Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.

•We developed a novel protocol for HBV vaccine production using the preS region.•This novel vaccine makes use of the binding capacity of biotin and streptavidin.•This vaccine has greater immunogenic potential than currently available vaccines.•This novel vaccine exerts not only a prophylactic role but also a therapeutic role.